MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · IEX Real-Time Price · USD
4.920
-0.100 (-1.99%)
At close: Jul 19, 2024, 4:00 PM
4.800
-0.120 (-2.44%)
Pre-market: Jul 22, 2024, 4:46 AM EDT

MacroGenics Revenue

MacroGenics had revenue of $43.36M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $9.10M. In the year 2023, MacroGenics had annual revenue of $58.75M.

Revenue (ttm)
$43.36M
Revenue Growth
-73.78%
P/S Ratio
7.11
Revenue / Employee
$127,897
Employees
339
Market Cap
308.16M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202358.75M-93.19M-61.33%
Dec 31, 2022151.94M74.49M96.19%
Dec 31, 202177.45M-27.44M-26.16%
Dec 31, 2020104.88M40.70M63.40%
Dec 31, 201964.19M4.07M6.76%
Dec 31, 201860.12M-97.62M-61.89%
Dec 31, 2017157.74M65.86M71.68%
Dec 31, 201691.88M-8.97M-8.90%
Dec 31, 2015100.85M53.06M111.00%
Dec 31, 201447.80M-10.24M-17.64%
Dec 31, 201358.04M-5.79M-9.07%
Dec 31, 201263.83M6.62M11.57%
Dec 31, 201157.21M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 703.37M
OraSure Technologies 304.64M
Aurora Cannabis 253.96M
Sutro Biopharma 154.07M
Pulmonx 72.99M
Enanta Pharmaceuticals 72.88M
Nyxoah 5.57M
Opthea 385.28K
Revenue Rankings